ABSTRACT
Introduction Chemotherapy, endocrine treatment, and the newer targeted agents are used as systemic adjuvant treatment after curative surgery or as palliative treatment for metastatic disease in patients with various malignancies. However, these treatments do not benefit all patients and may cause serious toxicity. Therefore, factors that predict response/toxicity to systemic treatments are urgently needed.
